← United States · Coverage record
US · SEC FORM 4
BRISTOL MYERS SQUIBB CO
BMY · NYSE · CIK 0000014272 · Healthcare · Drug Manufacturers—General
INSIDER SIGNAL
0 qualifying P purchase groups
in the current 180-day scoring window
16 Form 4 transaction lines observed in the same window
2 sales · 14 option, withholding, award, gift or other lines
WHY NO ACTIVE SIGNAL?
Score anatomy
No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.
Why is there no score?
- No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
- Sales and other Form 4 activity remain visible as context and do not create a negative score.
Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
—
Purchase breadth, concentration & cluster buying
These modules activate when qualifying purchases enter the 180-day research window.
SIGNAL HISTORY
Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2025-04-25 · Hirawat Samit.
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.
Price performance
- 1M
- -6.0%
- 3M
- +11.2%
- 6M
- +3.5%
- 12M
- —
Volatility & liquidity
- Volatility
- 27.5%
- Beta
- —
- Avg daily value
- —
Valuation
- Market cap
- —
- P/E
- —
Fundamentals
- Profit margin
- 14.6%
- ROE
- 38.2%
- Industry
- Drug Manufacturers—General
Market data
Price data up to: 2026-09-30 · Price source: OpenBB/yfinance · From SEC filings: Profit margin, ROE · Fiscal year ended: 2025-12-31 · Status: PASS
Short interest
Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.
- Shares short
- 45,847,626
- Previous report
- 41,969,577
- Avg daily volume
- 15,248,539
- Days to cover
- 3.0
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2025-04-25 | Hirawat Samit | Purchase (P) | Common Stock, $0.10 par value | 4,250 | USD 47.58 | USD 202,215 | SEC filing ↗ |
| 2025-02-20 | BOERNER CHRISTOPHER S. | Purchase (P) | Common Stock, $0.10 par value | 2,000 | USD 55.05 | USD 110,100 | SEC filing ↗ |
| 2025-02-14 | Hirawat Samit | Purchase (P) | Common Stock, $0.10 par value | 1,823 | USD 54.84 | USD 100,000 | SEC filing ↗ |
| 2024-11-01 | Hirawat Samit | Purchase (P) | Common Stock, $0.10 par value | 1,830 | USD 54.68 | USD 100,064 | SEC filing ↗ |
| 2023-12-05 | BOERNER CHRISTOPHER S. | Purchase (P) | Common Stock, $0.10 par value | 2,000 | USD 49.78 | USD 99,560 | SEC filing ↗ |
| 2023-11-28 | BOERNER CHRISTOPHER S. | Purchase (P) | Common Stock, $0.10 par value | 3,071 | USD 48.86 | USD 150,049 | SEC filing ↗ |
| 2023-11-20 | Samuels Theodore R. II | Purchase (P) | Common Stock, $0.10 par value | 8,500 | USD 49.81 | USD 423,385 | SEC filing ↗ |
| 2020-06-15 | Paliwal Dinesh C | Purchase (P) | Common Stock, $0.10 par value | 9,174 | USD 54.50 | USD 499,983 | SEC filing ↗ |
Form 4 evidence
138 transaction lines in the latest 365-day window; 1,157 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-10-02 | Gallman Cari | Option exercise / conversion (M) | Common Stock, $0.10 par value | 4,559 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-10-02 | Gallman Cari | Tax withholding (F) | Common Stock, $0.10 par value | 2,332 | USD 61.15 | USD 142,602 | SEC filing ↗ |
| 2026-09-09 | Massacesi Cristian | Sale (S) | Common Stock, $0.10 par value | 6,249 | USD 64.57 | USD 403,498 | SEC filing ↗ |
Show recent Form 4 evidence (30 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-10-02 | Gallman Cari | Option exercise / conversion (M) | Common Stock, $0.10 par value | 4,559 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-10-02 | Gallman Cari | Tax withholding (F) | Common Stock, $0.10 par value | 2,332 | USD 61.15 | USD 142,602 | SEC filing ↗ |
| 2026-09-09 | Massacesi Cristian | Sale (S) | Common Stock, $0.10 par value | 6,249 | USD 64.57 | USD 403,498 | SEC filing ↗ |
| 2026-09-01 | Short Bartie Wendy | Option exercise / conversion (M) | Common Stock, $0.10 par value | 1,236 | USD 66.92 | USD 82,713 | SEC filing ↗ |
| 2026-09-01 | Short Bartie Wendy | Tax withholding (F) | Common Stock, $0.10 par value | 633 | USD 66.92 | USD 42,360 | SEC filing ↗ |
| 2026-08-25 | Holzer Phil M | Sale (S) | Common Stock, $0.10 par value | 500 | USD 67.50 | USD 33,750 | SEC filing ↗ |
| 2026-08-01 | Massacesi Cristian | Option exercise / conversion (M) | Common Stock, $0.10 par value | 51,172 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-08-01 | Massacesi Cristian | Tax withholding (F) | Common Stock, $0.10 par value | 26,175 | USD 65.31 | USD 1,709,489 | SEC filing ↗ |
| 2026-08-01 | Gallman Cari | Option exercise / conversion (M) | Common Stock, $0.10 par value | 1,061 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-08-01 | Gallman Cari | Tax withholding (F) | Common Stock, $0.10 par value | 543 | USD 65.31 | USD 35,463 | SEC filing ↗ |
| 2026-06-15 | Haller Julia A | Option exercise / conversion (M) | Common Stock, $0.10 par value | 20,460 | USD 53.76 | USD 1,099,930 | SEC filing ↗ |
| 2026-06-03 | Short Bartie Wendy | Option exercise / conversion (M) | Common Stock, $0.10 par value | 8,040 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-03 | Short Bartie Wendy | Tax withholding (F) | Common Stock, $0.10 par value | 3,876 | USD 54.72 | USD 212,095 | SEC filing ↗ |
| 2026-05-01 | Lenkowsky Adam | Option exercise / conversion (M) | Common Stock, $0.10 par value | 1,373 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-01 | Lenkowsky Adam | J (J) | Common Stock, $0.10 par value | 203 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-01 | Lenkowsky Adam | Tax withholding (F) | Common Stock, $0.10 par value | 599 | USD 58.22 | USD 34,874 | SEC filing ↗ |
| 2026-04-01 | Shanahan Karin | Option exercise / conversion (M) | Common Stock, $0.10 par value | 3,307 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-04-01 | Shanahan Karin | Tax withholding (F) | Common Stock, $0.10 par value | 1,692 | USD 61.73 | USD 104,447 | SEC filing ↗ |
| 2026-04-01 | Elkins David V | Sale (S) | Common Stock, $0.10 par value | 30,000 | USD 61.67 | USD 1,850,016 | SEC filing ↗ |
| 2026-03-10 | Short Bartie Wendy | Option exercise / conversion (M) | Common Stock, $0.10 par value | 5,883 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-03-10 | Short Bartie Wendy | J (J) | Common Stock, $0.10 par value | 2,360 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-03-10 | Short Bartie Wendy | Tax withholding (F) | Common Stock, $0.10 par value | 1,275 | USD 60.13 | USD 76,666 | SEC filing ↗ |
| 2026-03-10 | Shanahan Karin | Option exercise / conversion (M) | Common Stock, $0.10 par value | 25,501 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-03-10 | Shanahan Karin | J (J) | Common Stock, $0.10 par value | 10,333 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-03-10 | Shanahan Karin | Tax withholding (F) | Common Stock, $0.10 par value | 7,760 | USD 60.13 | USD 466,609 | SEC filing ↗ |
| 2026-03-10 | Poole Ahn Amanda | Option exercise / conversion (M) | Common Stock, $0.10 par value | 6,436 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-03-10 | Poole Ahn Amanda | J (J) | Common Stock, $0.10 par value | 2,546 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-03-10 | Poole Ahn Amanda | Tax withholding (F) | Common Stock, $0.10 par value | 1,992 | USD 60.13 | USD 119,779 | SEC filing ↗ |
| 2026-03-10 | Plenge Robert M | Option exercise / conversion (M) | Common Stock, $0.10 par value | 17,501 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-03-10 | Plenge Robert M | J (J) | Common Stock, $0.10 par value | 7,277 | USD 0.00 | USD 0 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | BMY |
| CIK | 0000014272 |
| Sector | Healthcare |
| Industry | Drug Manufacturers—General Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| Exchange | NYSE |
Data coverage
| Local Form 4 history | 1,157 transaction lines from 2020-02-04 to 2026-10-02 8 P purchase lines · 61 S sale lines · 1,088 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.